For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.
Methodist Estabrook Cancer Center Designated a Care Continuum Center of Excellence for Lung CancerPublished: March 16, 2021
Methodist Estabrook Cancer Center (MECC) is proud to announce that it has been designated as a Care Continuum Center of Excellence by GO2 Foundation for Lung Cancer (GO2 Foundation). Methodist Hospital joins more than 60 other community hospitals – and is the first in Nebraska – to be honored with the designation, which recognizes commitment to improving outcomes for those diagnosed with lung cancer by providing patient-focused and coordinated multidisciplinary care. GO2 Foundation formed the Care Continuum Centers of Excellence program to enable patient access to standard-of-care lung cancer screening, early detection, diagnosis, treatment and survivorship in their local community.
“Methodist is dedicated to providing patients with the highest quality care,” said Deborah Meyers, BSN, OCN, program manager for the MECC lung cancer clinic. “Partnering with GO2 Foundation enables us to deliver even more resources to support lung cancer patients and their families. We’re proud of our team and the impact we are having on our local community.”
The Care Continuum Centers of Excellence program recognizes community hospitals that meet rigorous qualifying criteria that demonstrate collaborative leadership across the lung cancer care continuum. Meeting the criteria puts member hospitals on par with leading academic and research institutions while providing patients with access to the latest innovations not typically found in community hospitals. The Care Continuum Centers of Excellence approach results in patients receiving compassionate and timely care, as well as treatment options that improve survivorship.
“We are proud and honored to be working with the staff at Methodist Estabrook Cancer Center as a GO2 Foundation Care Continuum Center of Excellence,” said Laurie Fenton Ambrose, cofounder, president and CEO of GO2 Foundation. “Their commitment will help save lives and improve long-term survivorship by giving patients access to high-quality, multidisciplinary care closer to home. They are the example to follow.”